Correlation Between Monte Rosa and Werewolf Therapeutics

Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Monte Rosa Therapeutics and Werewolf Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Werewolf Therapeutics.

Diversification Opportunities for Monte Rosa and Werewolf Therapeutics

0.03

Correlation Coefficient

Monte Rosa  Werewolf Therapeutics

Significant diversification

The 3 months correlation between Monte and Werewolf is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Werewolf Therapeutics go up and down completely randomly.

Pair Corralation between Monte Rosa and Werewolf Therapeutics

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to under-perform the Werewolf Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Monte Rosa Therapeutics is 1.2 times less risky than Werewolf Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Werewolf Therapeutics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  222.00  in Werewolf Therapeutics on July 20, 2024 and sell it today you would lose (17.00) from holding Werewolf Therapeutics or give up 7.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Monte Rosa Therapeutics  vs.  Werewolf Therapeutics

Monte Rosa Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

Werewolf Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Werewolf Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in November 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Monte Rosa and Werewolf Therapeutics

The main advantage of trading using opposite Monte Rosa and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.

The idea behind Monte Rosa Therapeutics and Werewolf Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.